Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Paclitaxel × Clear all

Sponsor

Conditions

Breast Neoplasms 155 Carcinoma, Non-Small-Cell Lung 133 Ovarian Neoplasms 78 Lung Neoplasms 48 Fallopian Tube Neoplasms 47 Neoplasms 41 Triple Negative Breast Neoplasms 29 Neoplasm Metastasis 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Esophageal Neoplasms 19 Stomach Neoplasms 18 Carcinoma, Ovarian Epithelial 18 Head and Neck Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Adenocarcinoma of Lung 15 Endometrial Neoplasms 14 Breast Neoplasms, Male 14 Urinary Bladder Neoplasms 12 Melanoma 12 Recurrence 10 Carcinoma 10 Uterine Cervical Neoplasms 9 Brenner Tumor 9 Adenocarcinoma Of Esophagus 9 Peritoneal Neoplasms 8 Carcinoma, Squamous Cell 8 Small Cell Lung Carcinoma 7 Prostatic Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Adenocarcinoma, Bronchiolo-Alveolar 7

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡